Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) Interest Coverage Ratio: 9.04x

The interest coverage ratio for Medtronic plc (MDT) is 9.04x as of Wednesday, June 10, 2026.

MDT Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

9.04x

MDT Competitors' Interest Coverage Ratio

NAMEMARKET CAPINTEREST COVERAGE RATIOTTM3Y5Y
Medtronic plc (MDT)9.04xN/AN/AN/A
Vertex Pharmaceuticals Incorporated (VRTX)$110.77B357.95x357.95x174.48x123.56x
Bristol-Myers Squibb Company (BMY)$114.14B8.41x6.69x7.04x6.41x
Elevance Health Inc. (ELV)$87.43B5.79x6.64x7.93x8.79x
CVS Health Corporation (CVS)$125.16B3.33x3.10x3.72x4.16x
Cigna Corporation (CI)$78.25B6.61x6.58x6.49x6.37x
Danaher Corporation (DHR)$130.25B19.38x19.02x23.18x23.65x
Regeneron Pharmaceuticals, Inc. (REGN)$62.59B81.69x77.00x76.06x87.20x
Pfizer Inc. (PFE)$146.36B5.78x5.55x10.96x11.04x
Intuitive Surgical, Inc. (ISRG)$146.44BN/A55.58x55.58x55.58x

Financial Health Indicators

Interest Coverage

9.0x

Debt/Equity

0.00

Current Ratio

0.00

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

  • < 1.5x: EBIT is less than 1.5 times interest expense
  • 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
  • 3x - 5x: EBIT is between 3 and 5 times interest expense
  • > 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Medtronic plc Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medtronic plc Interest Coverage Ratio FAQ

What is the interest coverage ratio for Medtronic plc (MDT)?
The interest coverage ratio for MDT stock is 9.04x.

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha